Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Randomized Experiments01:13

Randomized Experiments

6.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.9K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

92
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
92
Crossover Experiments01:16

Crossover Experiments

2.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K
Controls in Experiments01:13

Controls in Experiments

7.4K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
7.4K
Group Design02:01

Group Design

8.9K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Coordination Single-Atom Nanozyme-Based Colorimetric-Photothermal Sensing Platform for Evaluation of Total Antioxidant Capacity.

Analytical chemistry·2026
Same author

Single-cell RNA Sequencing Discovered Subtypes Associated with Angiogenesis and Propranolol Treatment in Infantile Hemangioma.

Genomics, proteomics & bioinformatics·2026
Same author

The double-edged sword of Dioscorea bulbifera L.: Recent advances in its pharmacological benefits and hepatotoxicity, and the quest for detoxification strategies.

Journal of ethnopharmacology·2026
Same author

Bayesian randomized basket trial design: a case study from the ultra-rare invasive mold infections.

Biometrics·2026
Same author

Trajectories of childhood atopic dermatitis and their association with attention-deficit hyperactivity disorder.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025
Same author

The ethylene biosynthesis enzyme ACS3 acts as a key regulator of grain yield in rice.

Molecular breeding : new strategies in plant improvement·2025

Related Experiment Video

Updated: Jun 23, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Propensity score weighted multi-source exchangeability models for incorporating external control data in randomized

Wei Wei1, Yunxuan Zhang1, Satrajit Roychoudhury2

  • 1Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut.

Statistics in Medicine
|June 26, 2024
PubMed
Summary

This study introduces a novel method combining propensity score weighting (PW) and multi-source exchangeability modeling (MEM) to enhance randomized clinical trials (RCTs). The PW-MEM approach improves treatment effect precision and reduces bias when augmenting control arms with external data, especially for rare diseases.

Keywords:
Bayesian designhybrid controlpediatric studyrare disease

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

5.9K

Related Experiment Videos

Last Updated: Jun 23, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

5.9K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Drug Development

Background:

  • Growing interest in utilizing external data to enhance randomized clinical trials (RCTs) and expedite drug development.
  • Need for robust methods to augment control arms in RCTs, particularly in rare disease settings where patient recruitment is challenging.

Purpose of the Study:

  • To propose and evaluate a novel approach, Propensity Score Weighting-Multi-Source Exchangeability Modeling (PW-MEM), for augmenting the control arm of RCTs using external data.
  • To improve the precision of treatment effect estimates and mitigate biases when incorporating external control data in clinical trials.

Main Methods:

  • Combines propensity score weighting (PW) to create comparable external controls based on pre-treatment characteristics.
  • Employs multi-source exchangeability modeling (MEM) to assess outcome distribution similarity between weighted external and concurrent controls.
  • Determines the optimal amount of external data to borrow based on observed similarities.

Main Results:

  • The PW-MEM method demonstrated improved precision in treatment effect estimation compared to competing approaches.
  • The proposed method effectively reduced biases typically associated with borrowing data from external sources.
  • PW-MEM is applicable to various data types, including binary, continuous, and count data.

Conclusions:

  • The PW-MEM approach offers a statistically sound and effective strategy for augmenting control arms in RCTs with external data.
  • This method holds significant promise for accelerating drug development and improving decision-making in clinical trials, especially for rare diseases.
  • PW-MEM enhances the reliability of trial results by balancing the use of internal and external data sources.